Search

Search Constraints

You searched for: Author/Creator Calles, Antonio

Search Results

1. A phase 1b study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumours. (November 2018)

2. Aligning digital CD8+ scoring and targeted next‐generation sequencing with programmed death ligand 1 expression: a pragmatic approach in early‐stage squamous cell lung carcinoma1. Issue 2 (3rd November 2017)

3. Efficacy of Pembrolizumab Monotherapy in Patients With or Without Brain Metastases From Advanced Non–Small Cell Lung Cancer With a PD-L1 Expression ≥50%. Issue 9 (November 2020)

4. Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital. (24th May 2022)

5. Expression of PD-1 and Its Ligands, PD-L1 and PD-L2, in Smokers and Never Smokers with KRAS-Mutant Lung Cancer. Issue 12 (December 2015)

6. From presentation to paper: Gender disparities in oncological research. Issue 11 (11th October 2019)

7. Genomic and pathological heterogeneity in clinically diagnosed small cell lung cancer in never/light smokers identifies therapeutically targetable alterations. Issue 1 (25th November 2020)

8. Impact of performance status on non-small-cell lung cancer patients with a PD-L1 tumour proportion score ≥50% treated with front-line pembrolizumab. (1st September 2020)

9. Lung cancer patients with COVID-19 in Spain: GRAVID study. (July 2021)